longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Globus Medical Inc

GMED

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 18.69, within the reasonable range, cheaper than 79.23% of the time in the past 1 years, and the industry ranks 13/175, the industry Median -0.77.

18.69xP/E
$74.52Stock price
$3.99Earnings per share
18.69xP/E
Stock price$74.52Earnings per share$3.99

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
22.15x
Typical range
18.64x–27.66x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
MDTUSMedtronic
21.68x26.73%$113.38B
SYKUSStryker
28.02x53.09%$104.47B
BSXUSBoston Scientific
17.32x36.31%$63.65B
RMDUSResmed
21.02x11.53%$32.02B
GEHCUSGE HealthCare Tech
15.16x2.63%$30.10B
RYLPFUSKoninklijke Philips N.V.
18.41x--$23.81B
PHGUSKoninklijke Philips Elect
18.87x16.23%$24.40B
TRUMYUSTerumo
20.48x--$21.52B
STEUSSteris
25.31x17.10%$20.37B
ZBHUSZimmer Biomet
21.53x37.01%$17.36B
SNNUSSmith and Nephew
17.82x42.74%$11.32B
GMEDUSGlobus Medical Inc
18.69x6.02%$10.01B
PODDUSInsulet
25.16x76.42%$9.44B
SSMXYUSSysmex
29.02x--$7.34B
LIVNUSLivanova
22.39x189.82%$4.22B
TMDXUSTransMedics
19.50x71.90%$2.96B
INSPUSInspire Medical
15.09x100.86%$2.04B
LMATUSLemaitre Vascular
28.36x13.99%$1.86B
CNMDUSConmed
24.06x156.95%$1.36B
TCMDUSTactile
20.71x36.59%$514.89M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.